Goldman Sachs
TLSA icon

Goldman Sachs’s Tiziana Life Sciences TLSA Stock Holding History

Goldman Sachs’s Portfolio TLSA Stock Details TLSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$153K Buy
119,238
+43,578
+58% +$56.6K ﹤0.01% 6269
2026
Q1 		$88.5K Sell
75,660
-34,630
-31% -$49K ﹤0.01% 6226
2025
Q4 		$164K Buy
110,290
+88,830
+414% +$160K ﹤0.01% 6089
2025
Q3 		$46.4K Buy
+21,460
New +$39.7K ﹤0.01% 6179
2022
Q1 		– Sell
-25,370
Closed -$24K – 6908
2021
Q4 		$24K Buy
+25,370
New +$33.6K ﹤0.01% 6351
2021
Q1 		– Sell
-14,566
Closed -$29K – 6353
2020
Q4 		$29K Buy
+14,566
New +$46K ﹤0.01% 5423

Other funds holding TLSA

DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
MAWAG
Mid-American Wealth Advisory Group Kansas City, Missouri $277M AUM 6.22% 1-Year Est. Return
ZF
Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Goldman Sachs's TLSA Position: Q2 2026 in Review

Goldman Sachs increased its Tiziana Life Sciences (TLSA) stake by 58% in Q2 2026, buying an estimated $56.6K and bringing the position to 119,238 shares worth $153K. The position accounts for ﹤0.01% of the portfolio, ranked #6269.

Goldman Sachs first reported a position in TLSA in Q4 2020 and has held it in 6 quarters since. The position peaked at $164K in Q4 2025. 31 funds tracked by Wall St. Rank hold TLSA as of Q2 2026.

  • Goldman Sachs held 119,238 shares of Tiziana Life Sciences worth $153K as of Q2 2026.
  • Goldman Sachs bought 43,578 Tiziana Life Sciences shares in Q2 2026, an estimated $56.6K.
  • Tiziana Life Sciences made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #6269 holding.
  • Goldman Sachs first reported a position in Tiziana Life Sciences in Q4 2020 and has held it in 6 quarters since.
  • Goldman Sachs's Tiziana Life Sciences position peaked at $164K in Q4 2025.
  • 31 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.